 |
USING DISEASE FREE SURVIVAL (DFS) AS A PRIMARY ENDPOINT IN EARLY BREAST CANCERIDDI in collaboration with Roche have identified why using disease-free survival as a primary endpoint in early breast cancer is the way forward!
READ ARTICLE HERE |
|
|
 |
BAYESIAN OUTCOME-ADAPTIVE RANDOMIZATION DESIGNS: A PROMISE NOT WITHOUT PERILLearn on the principles of OAR designs – The key considerations for implementing Bayesian OAR designs and potential challenges ahead – The impact of selected elements of OAR designs on operational characteristics of a clinical trial – The advantages and disadvantages of OAR designs.
ON-DEMAND WEBINAR AVAILABLE HERE |
|
|
|
TALENT SPOTLIGHT |
 |
Elisabeth (Els) Coart, M.Sc, PhD, Director, Consulting Services Els joined IDDI in 2011, initially for research work related to biomarkers in Alzheimer’s disease. She has a strong background in assay development combined with 10 years’ experience as statistician for biotech and diagnostic industries. Over the past several years, Els has gained comprehensive experience in study design for oncology and has become IDDI’s expert in analytical and clinical validation of (companion) diagnostics, or IVDs. She has represented IDDI in symposia, publications, and countless interactions with prospects and clients. Els shares her high level of expertise with our team of consultants and has been instrumental in making this team grow over the last couple of years. |
|
|
|
FAST GROWING COMPANY |
 |
OPENING OF A SECOND EUROPEAN OFFICEIDDI has opened a new office in Mont-Saint-Guibert, Belgium to accommodate accelerated growth. This new location houses up to 40 additional employees. |
 |
MORE THAN 20 NEW EMPLOYEES SINCE BEGINNING OF THE YEARInterested in joining us? View our career page! Tremendous opportunities in Belgium and in the US. Apply today!
VIEW OUR CAREER PAGE |
|
|
| UPCOMING EVENTSWe look forward to meeting you at one of those following events! |
 |
| CONFERENCE & MEETINGS |
WEBINAR & PRESENTATIONS |
9ème Journée de la Recherche Clinique
Paris, France, January 30, 20205th Annual Biomarker & Companion Diagnostics
San Diego, CA, USA, February 6-75th European Conference on Clinical Research
Amsterdam, The Netherlands, February 10-11
Clinical Operations in Oncology Trials Southern California 2020
San Diego, CA, USA February 12-13
DIA Europe
Brussels, Belgium, March 17-20
BIO-EUROPE SPRING
Paris, France, March 23-25
MassBio’s Annual Meeting
Boston, MA, USA, March 25 – 26, 2020
Outsourcing in Clinical Trials Southeast
Durham, NC, USA, March 31-April 1, 2020 |
Validating Surrogate Endpoints in Oncology: From Theory to Practice!On-demand presentations and recording
Bayesian Outcome-Adaptive Designs: A promise not without Peril
On-demand webinar
Expansion Cohorts in Early Development of Anticancer Agents
On-demand webinar
Assessing Treatment Benefit in Immuno-Oncology
On-demand webinar
A New Statistical Method: Generalized Pairwise Comparisons
On-demand webinar
Treatment Allocation in Randomized Trials: Challenges and Best Practices
On-demand webinar |
| VIEW MORE EVENTS |
VIEW MORE ON-DEMAND WEBINARS |
|
